FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Astrazeneca Pharma India LtdIndustry : Pharmaceuticals - Multinational
BSE Code:506820 P/E (TTM) :106.38
ISIN Demat:INE203A01020 Div & Yield %:0.36 EPS (TTM) :84.59
Book Value (RS) :308.14 Market Cap (Rs Cr.):22496.13 Face Value (RS) :2
    Change Company 
Particulars Quarter Ended
(Jun 2025)		 Quarter Ended
(Jun 2024)		 Quarter Ended
(% Var)
Sales 526.31 387.52 35.81
Other Income 11.24 8.35 34.61
PBIDT 91.99 -11.14 0.00
Interest 0.72 0.11 554.55
PBDT 91.27 -11.25 0.00
Depreciation 16.57 3.91 323.79
PBT 74.70 -15.16 0.00
Tax 22.10 10.75 105.58
Deferred Tax -3.23 -14.12 0.00
PAT 55.83 -11.79 0.00

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)